Pediatric Indication (Down Syndrome)
OSA in Pediatric Patients with Down Syndrome
FDA ApprovedCommercial Launch
Key Facts
Indication
OSA in Pediatric Patients with Down Syndrome
Phase
FDA Approved
Status
Commercial Launch
Company
About Inspire Medical Systems
Inspire Medical Systems' mission is to address the critical unmet need in obstructive sleep apnea (OSA) treatment by providing an effective, patient-friendly alternative to CPAP. The company has achieved significant commercial success with its FDA-approved Inspire upper airway stimulation system, establishing robust clinical evidence, broad insurance coverage, and a scalable commercial infrastructure in the United States. Its strategy centers on deepening market penetration through surgeon education, expanding clinical indications, and leveraging its first-mover advantage in a high-growth neuromodulation segment of the sleep apnea market.
View full company profile